Filing metadata

Accession number
0000905148-23-001028
Form type
Form 3
Filer
Acrivon Therapeutics, Inc.
CIK
CIK 1781174
Filed
Sep 28, 2023
Reporting period
Sep 26, 2023
Description
Initial ownership

Explore SEC Filings Hub